A Seattle woman has spoken out about her experience of using the Paxman Scalp Cooler System. Brynn Kemper was just 29-year-old when she was diagnosed with breast cancer. She used the Paxman Scalp Cooling System before, during and after the administration of chemotherapy to help retain her hair.
Paxman have been shortlisted in two categories for this year’s BritishAmerican Business TransAtlantic Growth (TAG) Awards – Small Gold Export Award and Family Run Business Silver Award.
According to The Yorkshire Post, UK exports have been shown to have risen by 11.3 per cent to £617bn when comparing Office for National Statistics (ONS) data from 2017 versus 2016.
Trade of goods with non-EU countries grew by 11.6 per cent, faster than with the EU at 10.9 per cent.
Paxman are justifiably proud to be credited as part of this surge and exported to 26 countries across five continents in 2017.
PAXMAN and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) have announced the signing of an exclusive licensing agreement for PAXMAN Scalp Cooler treatments in the Mexico market. Under the agreement, Teva will be responsible for the sales and marketing activities in Mexico.
A patient video, that explains what’s it like to use the Paxman Scalp Cooling System to prevent hair loss during chemotherapy, has been created to mark World Cancer Day.
Paxman’s Director of Sales & Training Claire Paxman, has been announced as one of this year’s ’Yorkshire 42 Under 42’.
Scalp cooling for chemo patients has been named as #12 in the top things to look out for in 2018.
CEO of Paxman Richard Paxman, was interviewed by ecancer at the recent San Antonio Breast Cancer Conference about how the Paxman Scalp Cooling system was reducing chemotherapy induced hair loss.
As of October 2017 the Paxman Scalp Cooling System has now been installed in 44 treatment sites across the United States in the first months since receiving clearance by The U.S. Food and Drug Administration (FDA). It is the only scalp cooler in the world to offer a single patient use cooling cap to each user.
Paxman are exhibiting at the San Antonio Breast Cancer Symposium (SABCS) 5-9 December 2017.